These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 1793066

  • 41. Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist.
    Albert DH, Magoc TJ, Tapang P, Luo G, Morgan DW, Curtin M, Sheppard GS, Xu L, Heyman HR, Davidsen SK, Summers JB, Carter GW.
    Eur J Pharmacol; 1997 Apr 23; 325(1):69-80. PubMed ID: 9151941
    [Abstract] [Full Text] [Related]

  • 42. Pentadienyl carboxamide derivatives as antagonists of platelet-activating factor.
    Guthrie RW, Kaplan GL, Mennona FA, Tilley JW, Kierstead RW, Mullin JG, LeMahieu RA, Zawoiski S, O'Donnell M, Crowley H.
    J Med Chem; 1989 Aug 23; 32(8):1820-35. PubMed ID: 2754709
    [Abstract] [Full Text] [Related]

  • 43. Properties of ABT-299, a prodrug of A-85783, a highly potent platelet activating factor receptor antagonist.
    Albert DH, Conway RG, Magoc TJ, Tapang P, Rhein DA, Luo G, Holms JH, Davidsen SK, Summers JB, Carter GW.
    J Pharmacol Exp Ther; 1996 Jun 23; 277(3):1595-606. PubMed ID: 8667228
    [Abstract] [Full Text] [Related]

  • 44. Novel antagonists of platelet-activating factor. 1. Synthesis and structure-activity relationships of benzodiazepine and benzazepine derivatives of 2-methyl-1-phenylimidazo[4,5-c]pyridine.
    Fray MJ, Cooper K, Parry MJ, Richardson K, Steele J.
    J Med Chem; 1995 Sep 01; 38(18):3514-23. PubMed ID: 7658438
    [Abstract] [Full Text] [Related]

  • 45. Novel azo derivatives as prodrugs of 5-aminosalicylic acid and amino derivatives with potent platelet activating factor antagonist activity.
    Carceller E, Salas J, Merlos M, Giral M, Ferrando R, Escamilla I, Ramis J, García-Rafanell J, Forn J.
    J Med Chem; 2001 Aug 30; 44(18):3001-13. PubMed ID: 11520209
    [Abstract] [Full Text] [Related]

  • 46. Development, synthesis, and biological evaluation of (-)-trans-(2S,5S)-2-[3-[(2-oxopropyl)sulfonyl]-4-n-propoxy-5-(3- hydroxypropoxy)-phenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran, a potent orally active platelet-activating factor (PAF) antagonist and its water-soluble prodrug phosphate ester.
    Girotra NN, Biftu T, Ponpipom MM, Acton JJ, Alberts AW, Bach TN, Ball RG, Bugianesi RL, Parsons WH, Chabala JC.
    J Med Chem; 1992 Sep 18; 35(19):3474-82. PubMed ID: 1404229
    [Abstract] [Full Text] [Related]

  • 47. ABT-491, a highly potent and selective PAF antagonist, inhibits nasal vascular permeability associated with experimental allergic rhinitis in brown Norway rats.
    Albert DH, Tapang P, Morgan DW, Curtin ML, Sheppard GS, Davidsen SK, Summers JB, Carter GW.
    Inflamm Res; 1997 Aug 18; 46 Suppl 2():S133-4. PubMed ID: 9297547
    [No Abstract] [Full Text] [Related]

  • 48. Modulation of pulmonary inflammation after endotoxin inhalation with a platelet-activating factor antagonist (48740 RP).
    Rylander R, Beijer L, Lantz RC, Burrell R, Sedivy P.
    Int Arch Allergy Appl Immunol; 1988 Aug 18; 86(3):303-7. PubMed ID: 3403044
    [Abstract] [Full Text] [Related]

  • 49. Studies on the hypotensive effects of platelet activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine) in rats, guinea pigs, rabbits, and dogs.
    Tanaka S, Kasuya Y, Masuda Y, Shigenobu K.
    J Pharmacobiodyn; 1983 Nov 18; 6(11):866-73. PubMed ID: 6668545
    [Abstract] [Full Text] [Related]

  • 50. Studies of platelet activating factor (PAF) antagonists from microbial products. II. Pharmacological studies of FR-49175 in animal models.
    Okamoto M, Yoshida K, Uchida I, Kohsaka M, Aoki H.
    Chem Pharm Bull (Tokyo); 1986 Jan 18; 34(1):345-8. PubMed ID: 2421924
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Essential role of platelet-activating factor receptor in the pathogenesis of Dengue virus infection.
    Souza DG, Fagundes CT, Sousa LP, Amaral FA, Souza RS, Souza AL, Kroon EG, Sachs D, Cunha FQ, Bukin E, Atrasheuskaya A, Ignatyev G, Teixeira MM.
    Proc Natl Acad Sci U S A; 2009 Aug 18; 106(33):14138-43. PubMed ID: 19666557
    [Abstract] [Full Text] [Related]

  • 55. Sponge-induced angiogenesis and inflammation in PAF receptor-deficient mice (PAFR-KO).
    Ferreira MA, Barcelos LS, Campos PP, Vasconcelos AC, Teixeira MM, Andrade SP.
    Br J Pharmacol; 2004 Apr 18; 141(7):1185-92. PubMed ID: 15023865
    [Abstract] [Full Text] [Related]

  • 56. Role of PAF receptors during intestinal ischemia and reperfusion injury. A comparative study between PAF receptor-deficient mice and PAF receptor antagonist treatment.
    Souza DG, Pinho V, Soares AC, Shimizu T, Ishii S, Teixeira MM.
    Br J Pharmacol; 2003 Jun 18; 139(4):733-40. PubMed ID: 12812996
    [Abstract] [Full Text] [Related]

  • 57. Divergent mechanisms of action of the inflammatory cytokines interleukin 1-beta and tumour necrosis factor-alpha in mouse cremasteric venules.
    Young RE, Thompson RD, Nourshargh S.
    Br J Pharmacol; 2002 Dec 18; 137(8):1237-46. PubMed ID: 12466233
    [Abstract] [Full Text] [Related]

  • 58. Role of the platelet-activating factor (PAF) receptor during pulmonary infection with gram negative bacteria.
    Soares AC, Pinho VS, Souza DG, Shimizu T, Ishii S, Nicoli JR, Teixeira MM.
    Br J Pharmacol; 2002 Nov 18; 137(5):621-8. PubMed ID: 12381675
    [Abstract] [Full Text] [Related]

  • 59. Platelet-activating factor drives eotaxin production in an allergic pleurisy in mice.
    Klein A, Pinho V, Alessandrini AL, Shimizu T, Ishii S, Teixeira MM.
    Br J Pharmacol; 2002 Mar 18; 135(5):1213-8. PubMed ID: 11877329
    [Abstract] [Full Text] [Related]

  • 60. Ascaris suum-derived products induce human neutrophil activation via a G protein-coupled receptor that interacts with the interleukin-8 receptor pathway.
    Falcone FH, Rossi AG, Sharkey R, Brown AP, Pritchard DI, Maizels RM.
    Infect Immun; 2001 Jun 18; 69(6):4007-18. PubMed ID: 11349070
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.